Daniel LeSueur, Chief Operating Officer at Health Catalyst, Inc. (HCAT), sold 5,209 shares at $7.51 ($39K) on 2025-01-06, disclosed to the SEC on 2025-01-10.
Scheduled sale ($39k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| HCAT | SELL | 2025-03-10 | $153K | — | Filing → |
| HCAT | SELL | 2025-02-06 | $30K | — | Filing → |
| HCAT | SELL | 2024-12-06 | $351K | — | Filing → |